Relative Bioavailability of CE-Iohexol (Captisol-enabled™ Iohexol) Injection and Omnipaque™ Injection

Clinical trial NCT03869983 · COMPLETED

Trial details

NCT number: NCT03869983
Sponsor: CyDex Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Contrast-induced Nephropathy Coronary Angiography

Start date: 2019-04-12
Primary completion: 2019-05-15
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.